Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eucrates Biomedical Acquisition Corp. | 2,619,906 | reported | 24 Nov 2020 | tx 1−255,094 |
| Precipio, Inc. | 20,000 | reported | 01 Sept 2006 | tx 2+10,000 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | 8,200 | reported | 18 Dec 2025 | tx 12+1,118,800−540,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Dec 2025 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 8,200 | 0.00 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 8,200 | 0.00 USD | deriv |
| 13 Nov 2023 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 8,200 | 0.00 USD | deriv |
| 10 Nov 2022 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 3,900 | 0.00 USD | deriv |
| 08 Dec 2021 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 5,300 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 4,000 | 0.00 USD | deriv |
| 14 Dec 2020 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 197,500 | — | |
| 14 Dec 2020 | OTHER | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 343,000 | — | deriv |
| 14 Dec 2020 | GRANT_AWARD | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 197,500 | — | deriv |
| 15 Dec 2020 | OTHER | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 540,500 | — | deriv |
| 24 Nov 2020 | OTHER | Eucrates Biomedical Acquisition Corp. | 255,094 | — | |
| 30 Aug 2018 | PURCHASE | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 33,000 | 10.00 USD | |
| 23 Aug 2018 | PURCHASE | REVIVA PHARMACEUTICALS HOLDINGS, INC. | 310,000 | 10.00 USD | |
| 01 Sept 2006 | GRANT_AWARD | Precipio, Inc. | 5,000 | 0.00 USD | deriv |